Search
Avalon Globocare Corp
ALBTAdd to Watchlist
0.341USD
-0.006-1.79%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
4.11MMarket Cap
LossP/E TTM
More Details of Avalon Globocare Corp Company
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Avalon Globocare Corp Info
Ticker SymbolALBT
Company nameAvalon Globocare Corp
IPO dateFeb 22, 2016
CEOJin (David)
Number of employees5
Security typeOrdinary Share
Fiscal year-endFeb 22
Address4400 Route 9
CityFREEHOLD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07728
Phone17327804400
Websitehttps://www.avalon-globocare.com/
Ticker SymbolALBT
IPO dateFeb 22, 2016
CEOJin (David)
Company Executives of Avalon Globocare Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Secretary
Chief Operating Officer, Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Intracoastal Capital, L.L.C.
4.07%
Lu (Wenzhao)
1.98%
Jin (David)
0.85%
Armistice Capital LLC
0.83%
Vanguard Capital Management, LLC
0.48%
Other
91.79%
Shareholders
Shareholders
Proportion
Intracoastal Capital, L.L.C.
4.07%
Lu (Wenzhao)
1.98%
Jin (David)
0.85%
Armistice Capital LLC
0.83%
Vanguard Capital Management, LLC
0.48%
Other
91.79%
Shareholder Types
Shareholders
Proportion
Corporation
5.89%
Individual Investor
4.53%
Hedge Fund
1.21%
Investment Advisor
1.19%
Investment Advisor/Hedge Fund
0.28%
Venture Capital
0.12%
Other
86.77%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
30
83.03K
1.00%
-43.86K
2025Q4
29
48.23K
1.25%
--
2025Q3
31
48.23K
1.39%
+17.57K
2025Q2
33
19.75K
2.15%
+2.84K
2025Q1
33
16.91K
2.05%
-16.99K
2024Q4
35
16.66K
2.06%
-67.00
2024Q3
33
16.73K
1.75%
-236.00
2024Q2
33
16.96K
1.41%
+10.31K
2024Q1
31
6.65K
1.69%
-5.84K
2023Q4
32
10.45K
1.58%
+1.42K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Lu (Wenzhao)
238.93K
2.98%
--
--
Feb 17, 2026
Jin (David)
103.00K
1.28%
--
--
Oct 31, 2025
Li (Meng)
34.33K
0.43%
--
--
Feb 17, 2026
Geode Capital Management, L.L.C.
22.90K
0.29%
+824.00
+3.73%
Dec 31, 2025
Procyon Advisors, LLC
18.60K
0.23%
+18.60K
--
Dec 31, 2025
XTX Markets LLC
10.37K
0.13%
+10.37K
--
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
